ZA201107883B - Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containint these derivatives - Google Patents

Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containint these derivatives

Info

Publication number
ZA201107883B
ZA201107883B ZA2011/07883A ZA201107883A ZA201107883B ZA 201107883 B ZA201107883 B ZA 201107883B ZA 2011/07883 A ZA2011/07883 A ZA 2011/07883A ZA 201107883 A ZA201107883 A ZA 201107883A ZA 201107883 B ZA201107883 B ZA 201107883B
Authority
ZA
South Africa
Prior art keywords
derivatives
containint
hydroxybenzylamino
medicaments
substituted
Prior art date
Application number
ZA2011/07883A
Inventor
Radek Jorda
Vladimir Krystof
Igor Popa
Miroslav Strnad
Marek Zatloukal
Libor Havlicek
Karel Dolezal
Original Assignee
Univ Palackeho
Biopatterns S R O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Palackeho, Biopatterns S R O filed Critical Univ Palackeho
Publication of ZA201107883B publication Critical patent/ZA201107883B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D473/00—Heterocyclic compounds containing purine ring systems
    • C07D473/02—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6
    • C07D473/16—Heterocyclic compounds containing purine ring systems with oxygen, sulphur, or nitrogen atoms directly attached in positions 2 and 6 two nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Diabetes (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Transplantation (AREA)
  • Dermatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA2011/07883A 2009-06-03 2011-10-27 Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containint these derivatives ZA201107883B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CZ20090359A CZ302711B6 (en) 2009-06-03 2009-06-03 Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and pharmaceutical compositions comprising thereof
PCT/CZ2010/000067 WO2010139289A1 (en) 2009-06-03 2010-06-02 Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containing these derivatives

Publications (1)

Publication Number Publication Date
ZA201107883B true ZA201107883B (en) 2012-07-25

Family

ID=42983684

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2011/07883A ZA201107883B (en) 2009-06-03 2011-10-27 Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containint these derivatives

Country Status (5)

Country Link
US (1) US8492391B2 (en)
EP (1) EP2438068B1 (en)
CZ (1) CZ302711B6 (en)
WO (1) WO2010139289A1 (en)
ZA (1) ZA201107883B (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CZ302122B6 (en) * 2009-01-28 2010-10-20 Univerzita Palackého v Olomouci Substituted derivatives of 6-(2-aminobenzylamino)purine, their use as well as a medicament and compositions in which said derivatives are comprised
GB201110390D0 (en) * 2011-06-20 2011-08-03 Medical Res Council Compounds for use in stabilising p53 mutants
EP2634190A1 (en) * 2012-03-01 2013-09-04 Lead Discovery Center GmbH Pyrazolo-triazine derivatives as selective cyclin-dependent kinase inhinitors
CN104936959B (en) * 2013-03-08 2018-09-18 中国人民解放军军事医学科学院放射与辐射医学研究所 Tri- substituted purin derivatives of 2,6,9- and the preparation method and application thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU3540101A (en) * 2000-01-07 2001-07-16 Universitaire Instelling Antwerpen Purine derivatives, process for their preparation and use thereof
EP1348707B1 (en) * 2002-03-28 2010-08-25 Ustav Experimentalni Botaniky AV CR, v.v.i. (Institute of Experimental Botany Academy of Sciences of the Czech Republic, PRO) Pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy

Also Published As

Publication number Publication date
CZ2009359A3 (en) 2010-12-15
WO2010139289A1 (en) 2010-12-09
US20120070512A1 (en) 2012-03-22
EP2438068A1 (en) 2012-04-11
CZ302711B6 (en) 2011-09-14
EP2438068B1 (en) 2017-03-01
US8492391B2 (en) 2013-07-23

Similar Documents

Publication Publication Date Title
IL279304A (en) Cytotoxic benzodiazepine derivatives, compositions comprising the same and uses thereof
IL254076B (en) 5-fluoropyrimidinone derivatives, fungicidal compositions comprising them and methods for their use
IL256921A (en) Pyrazolopyrimidines, pharmaceutical compositions comprising thereof and uses thereof
IL232382A0 (en) Fused pyrimidine derivatives, compositions comprising the same and uses thereof
IL214175A (en) Aminotetraline derivatives, pharmaceutical compositions containing them and use thereof
IL216829A0 (en) Ureidophenyl substituted triazine derivatives, compositions comprising the same and uses thereof
IL216833A0 (en) Triazine derivatives, compositions comprising the same and uses thereof
IL216825A0 (en) Triazine derivatives, processes for producing the same, compositions comprising the same and uses thereof
IL210855A (en) Adenine derivatives
IL216826A0 (en) Pyridil-triazine derivatives, compositions comprising the same and processes for producing the same
EP2511283A4 (en) N6-substituted adenosine derivatives, n6-substituted adenine derivatives and uses thereof
HK1164050A1 (en) Substituted azoanthracene derivatives, pharmaceutical compositions, and methods of use thereof
IL232217A (en) Azole derivatives, pharmaceutical compositions comprising them and their uses
IL216832A0 (en) Triazine derivatives, processes for producing the same, compositions comprising the same and uses thereof
HK1176556A1 (en) N-9-substituted purine compounds, compositions and methods of use n-9-
IL221207A (en) Pyrazolo piperidine derivatives, compositions comprising the same and uses thereof
EP2562172A4 (en) Sphaelactone derivatives, their pharmaceutical compositions, preparation methods and uses
IL221209A0 (en) Pyrazolo piperidine derivatives, compositions comprising the same and uses thereof
IL219243A (en) 5-hydroxypyrimidine-4-carboxamide derivatives, compositions comprising the same and uses thereof
EP2386553A4 (en) Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
IL251177A0 (en) Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
EP2616477A4 (en) 6-substituted demethyl-estradiol derivatives as er-beta agonists
IL216831A0 (en) Triazine derivatives, compositions comprising the same and uses thereof
IL214408A0 (en) Derivatives of 6-(6-substituted-triazolopyidazine-sulfanyl) 5-fluoro-benzothiazoles and 5-fluoro-benzimidazoles, preparation thereof, use thereof as drugs, and use thereof as met inhibitors
ZA201107883B (en) Substituted 6-(2-hydroxybenzylamino)purine derivatives, their use as medicaments and compositions containint these derivatives